Seeyond’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$5.57M Buy
10,864
+4,773
+78% +$2.42M 0.54% 30
2022
Q3
$2.77M Sell
6,091
-272
-4% -$130K 0.33% 77
2022
Q2
$3.09M Buy
6,363
+103
+2% +$51K 0.35% 66
2022
Q1
$3.08M Buy
6,260
+497
+9% +$227K 0.31% 74
2021
Q4
$2.67M Sell
5,763
-40
-0.7% -$16.8K 0.25% 103
2021
Q3
$2.16M Buy
5,803
+137
+2% +$52.1K 0.21% 146
2021
Q2
$2.16M Sell
5,666
-293
-5% -$112K 0.2% 155
2021
Q1
$2.14M Buy
5,959
+1,696
+40% +$545K 0.21% 140
2020
Q4
$1.37M Sell
4,263
-495
-10% -$152K 0.14% 244
2020
Q3
$1.28M Buy
4,758
+177
+4% +$47.6K 0.14% 227
2020
Q2
$1.21M Sell
4,581
-1,379
-23% -$368K 0.14% 228
2020
Q1
$792K Sell
5,960
-1,329
-18% -$362K 0.11% 265
2019
Q4
$2.2M Sell
7,289
-1,875
-20% -$516K 0.23% 133
2019
Q3
$2.2M Sell
9,164
-565
-6% -$155K 0.23% 132
2019
Q2
$2.75M Sell
9,729
-1,343
-12% -$367K 0.29% 74
2019
Q1
$3.18M Buy
11,072
+5,486
+98% +$1.59M 0.3% 85
2018
Q4
$1.47M Buy
+5,586
New +$1.54M 0.2% 148

Other funds holding ELV

Seeyond's ELV Position: Q4 2022 in Review

Seeyond increased its Elevance Health (ELV) stake by 78% in Q4 2022, buying an estimated $2.42M and bringing the position to 10,864 shares worth $5.57M. The position accounts for 0.54% of the portfolio, ranked #30.

Seeyond first reported a position in ELV in Q4 2018 and has held it in 17 quarters since. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

  • Seeyond held 10,864 shares of Elevance Health worth $5.57M as of Q4 2022.
  • Seeyond bought 4,773 Elevance Health shares in Q4 2022, an estimated $2.42M.
  • Elevance Health made up 0.54% of Seeyond's portfolio in Q4 2022, its #30 holding.
  • Seeyond first reported a position in Elevance Health in Q4 2018 and has held it in 17 quarters since.
  • 1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on Seeyond's 13F filing for Q4 2022, filed 13 Feb 2023.